Though the JP Morgan Healthcare Conference wrapped a couple weeks ago, we’re still following up on the many meetings and exciting leads from the official BOCA Healthcare launch party. It was great to see clients, colleagues, media and friends mingle at 9 Kearny the first day of the conference, and hear about the amazing innovations being developed to improve healthcare.
While maybe not as fun as our BOCA party, the JP Morgan Healthcare conference is the biggest healthcare investing event in the U.S. and sets the tone for the market for the rest of the year. This year’s conference started off on a dour note with the Nasdaq Biotechnology Index closing near a 52-week low, but was buoyed both by the enthusiasm of nearly 400 startups and the big news of the Cancer Moon Shot initiative.
Announced during the President’s State of the Union address, the Cancer MoonShot 2020 aims to design, initiate and complete randomized clinical trials for all stages of cancer in up to 20 tumor types for as many as 20,000 patients by the year 2020. It’s ambitious and driven by an unprecedented collaboration of large pharma (Celgene and Amgen, biotech including NantWorks, NantKwest, Etubics, Altor Bioscience, and Precision Biologics), major academic cancer centers and community oncologists, Independence Blue Cross, and Bank of America -- which together make The National Immunotherapy Coalition (NIC).
Beyond this, much of the media conversation during the week focused on drug pricing. This was due in part to the circus that is Martin Shrekli. But the refrain heard again and again in the media was that the cost of prescription drugs was too high — even if they’re not the most expensive part of U.S. healthcare, as Dr. Ron Cohen reminded everyone.
What’s interesting to see is the shift at the JP Morgan Healthcare Conference has taken over the last few years to focus more on the health technology sector. While this sector has been in development for years, it’s only in the past year or so that the two worlds of technology and regulated healthcare have really started to come together. In an article predicting what the next big disruptor in healthcare will be, Business Insider looks at some of the more interesting technologies highlighted at the conference.
We’ll plan to cover more news and developments in the coming weeks, but in the meantime, please weigh in. What did you see that has incredible potential?